The production of IL-16 correlates with the onset and progression of gastrointestinal tumors, breast cancer, cutaneous T cell lymphoma (CTCL), and multiple myeloma (MM) [32,46]. This evidence concerns the gene IL16 and Miyoshi myopathy.